HeyJaredSushree Mohanty
- Indexed articles, last 90 days
- 65
- Latest publication
- Sep 22, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Broadcom Just Named Its Next AI Customer. It Isn’t Google. (opens the original)
Read excerpt
Broadcom's (AVGO) artificial intelligence (AI) story has been closely linked to Alphabet (GOOGL) for years now. The relationship is still getting bigger, with the company now expecting to supply Google with tens of billions of dollars of Tensor Processing Units (TPUs) each year over the next several years. However, Broadcom's third-quarter earnings call revealed there may be a new customer that is becoming increasingly important for the company. Who is Broadcom's next big AI customer and what do
Halliburton and SLB Are 2 Energy Stocks Riding the Oilfield Recovery. 1 Is Clearly the Better Buy. (opens the original)
Read excerpt
The Iran war has thrown the global oil market into turmoil, disrupting oil routes and supply across the Middle East. It has also exposed the risks of relying too heavily on concentrated supply sources. Yet these same issues have also pushed energy producers to think harder about production capacity, exploration, and investment in longer-term projects outside the most exposed areas. For Halliburton (HAL) and SLB (SLB), two of the world's largest oilfield-service companies, the bigger opportunity
Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round (opens the original)
Read excerpt
The obesity-drug market is now moving to a much more complicated phase. The first major battle was largely fought between two obesity injectable GLP-1 drugs, Eli Lilly's (LLY) Zepbound and Novo's (NVO) Wegovy. But this next round is increasingly becoming about oral treatments, higher-dose formulations, and next-generation drugs that could extend the market well beyond today's blockbuster therapies. For investors, it is no longer simply about which company sells the most weight-loss injections no
Ciena Stock Could Double on the Next AI Spending Wave. Here’s How to Play CIEN. (opens the original)
Read excerpt
Ciena (CIEN) may not be the first stock investors think of when AI comes up. But it could become one of the more interesting ways to play the boom. The company is benefiting from surging demand for the optical connectivity that links increasingly powerful data centers, creating a growth opportunity that may last well beyond the current AI cycle. Ciena stock has climbed roughly 34% so far in 2026. But according to Wall Street, if AI spending keeps accelerating, CIEN stock could double to reach $6
Oracle Is Slashing Payroll While Borrowing Billions for AI. What It Means for ORCL Stock. (opens the original)
Read excerpt
Oracle (ORCL) is in the limelight again, slashing jobs with one hand while it borrows billions of dollars with the other hand. The company has started another round of layoffs, with affected employees receiving termination notices beginning Sept. 14 as the company pushes ahead with a broader restructuring plan. Meanwhile, it faces an $89 billion debt problem that investors cannot overlook. While this may appear counterintuitive, there is a clear bet behind it. Oracle is shrinking some costs so i
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.